Schedule 13G ownership disclosure

Furiex Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 36106P101

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
Unavailable

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-15-000686
Form type
SC 13G/A
Filer
Consonance Capital Management LP
CIK
CIK 1544773
Filed
Feb 17, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub